BioMarin Pharmaceutical Inc. buy BiotechBee
Start price
24.06.23
/
60%
€85.44
Target price
31.07.25
€100.00
Performance (%)
-26.40%
End price
14.12.24
€62.88
Summary
This prediction ended on 14.12.24 with a price of €62.88. The prediction for BioMarin Pharmaceutical Inc. disappointed with a performance of -26.40%. BiotechBee has 60% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| BioMarin Pharmaceutical Inc. | -3.245% | -3.245% | -3.064% | -35.505% |
| iShares Core DAX® | 3.153% | 1.504% | 9.129% | 62.821% |
| iShares Nasdaq 100 | 7.431% | -1.584% | 28.642% | 85.805% |
| iShares Nikkei 225® | 8.571% | -4.324% | 53.026% | 77.327% |
| iShares S&P 500 | 4.578% | 1.920% | 23.965% | 69.680% |
According to BiotechBee what are the pros and cons of BioMarin Pharmaceutical Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread BioMarin Pharmaceutical Inc. diskutieren
Buy mit Kursziel 100,0